ArticleSouth Asian journal of cancer2022

Study of Gemcitabine Plus Nab-Paclitaxel-Based Chemotherapy Regimen as First-Line Treatment in Metastatic Pancreatic Carcinoma.

Kshitij Domadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.